PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
23-Sep-2024 Pentixapharm Holding AG Sets Price Range for Planned IPO Pentixapharm Holding AG
23-Sep-2024 Relief Therapeutics Announces $2 Million Milestone Under Royalty Sales Agreement Relief Therapeutics Holding SA
20-Sep-2024 BRAIN Biotech AG concludes major pharma compound transaction valued up to EUR 128.88 million from its BioIncubator BRAIN Biotech AG
20-Sep-2024 BRAIN Biotech AG concludes royalty monetization deal for up to EUR 128.88 million on investigational pharma compound deucrictibant with Royalty Pharma BRAIN Biotech AG
20-Sep-2024 Just – Evotec Biologics opens cutting-edge biologics facility - J.POD® Toulouse, France (EU) Evotec SE
19-Sep-2024 Ketabon To Present Advancements In At-Home Ketamine Therapy For Treatment-Resistant Depression At ECNP Congress 2024 Ketabon GmbH
19-Sep-2024 OEAW AND BOEHRINGER INGELHEIM FOUNDATION ESTABLISH NEW INSTITUTE FOR BIOMEDICAL ARTI-FICIAL INTELLIGENCE IN VIENNA Boehringer Ingelheim
19-Sep-2024 Xlife Sciences AG: Successful First Half of 2024 with Strategic Progress and Solid Financial Figures Xlife Sciences AG
19-Sep-2024 AEVIS VICTORIA SA – Publication of Half-Year Report 2024 – Revenue up 8.0% to CHF 527.6 million – Operating profit at EBITDAR level up 21.3% to CHF 87.7 million AEVIS VICTORIA SA
19-Sep-2024 Newron presents H1 2024 results and provides business update Newron Pharmaceuticals S.p.A.
18-Sep-2024 Marinomed Biotech AG resolves capital increase excluding statutory subscription rights by issuing 154,053 no-par value bearer shares at an issue price of EUR 5 per share Marinomed Biotech AG
18-Sep-2024 Mainz Biomed Announces Petra Smeltzer Starke to Join Company as Brand Ambassador Mainz BioMed N.V.
18-Sep-2024 Immunic Presents Key Vidofludimus Calcium Data at the 40th Congress of ECTRIMS, Highlighting Its Therapeutic Potential in Multiple Sclerosis Immunic AG
18-Sep-2024 RSSL announces opening of new laboratory to provide advanced 3D imaging and metrology services RSSL
18-Sep-2024 Relief Therapeutics Completes Clinical Phase in RLF-OD032 Proof-of-Concept Study; Topline Results Expected in October 2024 Relief Therapeutics Holding SA
17-Sep-2024 Cinven to sell minority stake in SYNLAB to strategic investor Labcorp SYNLAB AG
17-Sep-2024 Viromed Medical AG plans to acquire all shares of ActivCell Group AG by way of a capital increase against contribution in kind with exclusion of subscription rights Viromed Medical AG
17-Sep-2024 EPSA Team 2024-2025: Empowering Pharmaceutical Students Across Europe EPSA
17-Sep-2024 ImmunOs Therapeutics AG Raises $11 Million and Further Strengthens Investor Base ImmunOs Therapeutics
17-Sep-2024 Original-Research: SynBiotic SE (von NuWays AG) SynBiotic SE